Search Site

Trends banner

Tesla’s first Saudi showroom opens

The opening in Riyadh comes with Tesla sales dropping.

Mubadala Energy enters US energy market

Acquires a 24.1% interest in US firm Kimmeridge’s SoTex

Borouge to increase dividend from 2025

The company okayed $650 million final dividend for 2024.

TikTok’s US future uncertain

It must find non-Chinese owner to avoid ban.

Tesla Q1 sales sink 13 percent

The dip occurred amid lower production during factory upgrades.

Samsung boss goes on trial on drugs charges

The results were largely in line with Samsung's earlier forecast of a 77.9 percent fall in profit. (AFP)
  • Lee Jae-yong is accused of having repeatedly taken anaesthetic propofol at a plastic surgery clinic in Seoul in 2017 and 2018
  • Propofol is normally a medical anaesthetic but is also sometimes used recreationally

The de-facto leader of the sprawling Samsung group Lee Jae-yong went on trial Tuesday on charges of illegally using the anaesthetic propofol, the latest legal travail to beset the multi-billionaire.

Lee — the vice-chairman of the world’s biggest smartphone maker Samsung Electronics and according to Forbes the world’s 297th richest person — is accused of having repeatedly taken it at a plastic surgery clinic in Seoul in 2017 and 2018.

Propofol is normally a medical anaesthetic but is also sometimes used recreationally, and an overdose of the drug was given as the cause of pop star Michael Jackson’s death in 2009.

Usage is normally seen as a minor offence in the South and prosecutors originally proposed fining him 50 million won ($42,000) under a summary indictment, a procedure where less serious cases do not go to court. 

But the court overruled the prosecution and ordered a trial.

Wearing a dark grey business suit and a facemask, Lee remained tight-lipped as he entered the Seoul Central District Court, skipping questions from reporters. 

In court, prosecutors demanded a larger fine of 70 million won, Yonhap news agency reported.

Lee’s lawyers maintain the substance was administered for medical reasons. 

“It was prescribed in accordance with medical procedure by a doctor during Lee’s treatment,” they said in a statement.

Samsung Electronics declined to comment. 

The firm is the flagship subsidiary of the giant Samsung group, by far the largest of the family-controlled empires known as chaebols that dominate business in South Korea, the world’s 12th largest economy.

Lee became the conglomerate’s de facto leader following the death of his father last year.

Two months ago he was released early from a two and a half year prison term for bribery, embezzlement and other offences in connection with the corruption scandal that brought down ex-South Korean president Park Geun-hye.

The early release was seen as the latest example of South Korea freeing on economic grounds business leaders imprisoned for corruption or tax evasion.

Samsung Electronics subsequently announced a giant $205-billion investment plan, three-quarters of it planned for the South.

But Lee remains on trial on separate accusations of manipulating a takeover to smooth his succession at the top of the Samsung group — the same controversy over which he was said to have sought help from Park.